# In Vivo Leptin Signaling in Humans After Acute Leptin Administration

> **NCT01275053** · PHASE1 · COMPLETED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 12 (actual)

## Conditions studied

- Lean
- Obese
- Obese Diabetics

## Interventions

- **DRUG:** leptin

## Key facts

- **NCT ID:** NCT01275053
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** 2013-12
- **Final completion:** 2017-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01275053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01275053, "In Vivo Leptin Signaling in Humans After Acute Leptin Administration". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01275053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*